Revvity Inc. $RVTY Shares Acquired by California State Teachers Retirement System

California State Teachers Retirement System increased its holdings in Revvity Inc. (NYSE:RVTY - Free Report) by 10,607.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,328,063 shares of the company's stock after buying an additional 14,194,254 shares during the quarter. California State Teachers Retirement System owned about 12.84% of Revvity worth $1,594,140,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Angeles Wealth Management LLC lifted its holdings in Revvity by 2.0% in the 2nd quarter. Angeles Wealth Management LLC now owns 5,804 shares of the company's stock valued at $646,000 after acquiring an additional 112 shares during the last quarter. Syon Capital LLC grew its position in Revvity by 9.1% in the second quarter. Syon Capital LLC now owns 4,442 shares of the company's stock worth $494,000 after buying an additional 369 shares during the last quarter. NEOS Investment Management LLC increased its holdings in shares of Revvity by 13.2% in the second quarter. NEOS Investment Management LLC now owns 17,388 shares of the company's stock valued at $1,935,000 after buying an additional 2,031 shares in the last quarter. Nykredit A S bought a new position in shares of Revvity in the second quarter valued at $358,000. Finally, Headlands Technologies LLC acquired a new stake in shares of Revvity during the 2nd quarter valued at $370,000. 86.65% of the stock is currently owned by institutional investors.

Revvity Stock Performance

Shares of RVTY opened at $124.46 on Friday. The company has a market capitalization of $13.89 billion, a PE ratio of 59.27, a price-to-earnings-growth ratio of 2.20 and a beta of 1.09. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.80 and a quick ratio of 1.50. Revvity Inc. has a one year low of $81.22 and a one year high of $133.00. The company's fifty day moving average price is $117.71 and its 200 day moving average price is $103.21.

Revvity (NYSE:RVTY - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.20. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The company had revenue of $729.69 million for the quarter, compared to the consensus estimate of $702.96 million. During the same period last year, the business posted $1.18 earnings per share. The firm's revenue was down 1.3% compared to the same quarter last year. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, analysts expect that Revvity Inc. will post 5.36 earnings per share for the current year.

Revvity Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be paid a dividend of $0.07 per share. This represents a $0.28 annualized dividend and a dividend yield of 0.2%. The ex-dividend date of this dividend is Friday, October 23rd. Revvity's dividend payout ratio is 13.33%.

Analyst Ratings Changes

Several research analysts have commented on the stock. UBS Group initiated coverage on shares of Revvity in a report on Wednesday. They issued a "neutral" rating and a $140.00 target price for the company. Sanford C. Bernstein began coverage on shares of Revvity in a research report on Friday, June 26th. They issued a "market perform" rating and a $115.00 price target for the company. Zacks Research raised shares of Revvity from a "strong sell" rating to a "hold" rating in a research note on Tuesday, August 4th. TD Cowen reissued a "buy" rating on shares of Revvity in a research note on Wednesday, July 15th. Finally, Wall Street Zen downgraded Revvity from a "buy" rating to a "hold" rating in a research note on Sunday, August 16th. Four investment analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company's stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $116.57.

About Revvity

Revvity, Inc is a life sciences and diagnostics company that provides technologies, products and services used by researchers, healthcare professionals and laboratories. Its offerings support applications across genomics, proteomics, cellular analysis, drug discovery, disease research and laboratory testing.

The company develops and supplies scientific instruments, reagents, consumables, software and workflow solutions. Its portfolio includes platforms for genetic and molecular analysis, imaging, high-throughput screening, biomarker research and single-cell analysis, as well as laboratory solutions used in areas such as reproductive health and newborn screening.

Revvity was established in 2023 following the separation of PerkinElmer's Applied, Food and Enterprise Services businesses from its Precision Diagnostics operations.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.